MEDTRONIC PLC (MDT:NYSE)
$82 -3 (-3.5294%)
Analysed MEDTRONIC PLC (MDT:NYSE) News Sources
Medtronic (MDT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
21-04-2026
yahoo.com
Intuitive Surgical Earnings Show Big Beats Don’t Always Spark Stock Rallies
21-04-2026
yahoo.com
Study Supports GlucoTrack’s Blood Glucose Monitoring Implant
21-04-2026
yahoo.com
Is Medtronic (MDT) a Buy as Wall Street Analysts Look Optimistic?
21-04-2026
yahoo.com
During an Altaviva(TM) Implant, the Patient Talked About Lunch. That Was the Point
21-04-2026
yahoo.com
MiniMed posts double-digit sales growth, widening net loss
21-04-2026
medtechdive.com
Medtronic leads $100M investment in Pulnovo Medical
21-04-2026
medtechdive.com
Wearable Injectors Market Report 2026 (8th Edition) Featuring Analysis of BD, Enable Injections, Insulet, Medtronic, Tandem Diabetes Care, West Pharmaceutical Services, and Ypsomed
21-04-2026
yahoo.com
Medtronic concludes CathWorks’ acquisition for $585m
21-04-2026
medicaldevice-network.com
[Latest] Global Surgical Drill Bits Market Size/Share Worth USD 540 Million by 2035 at a 5.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
21-04-2026
yahoo.com
What is the current price of MEDTRONIC PLC (MDT:NYSE)?
The current price of MEDTRONIC PLC (MDT:NYSE) is $82.
MEDTRONIC PLC (MDT:NYSE) absolute price change since previous trading day?
The absolute price change of MEDTRONIC PLC (MDT:NYSE) since the previous trading day is $-3.
MEDTRONIC PLC (MDT:NYSE) percentage price change since previous trading day?
The percentage price change of MEDTRONIC PLC (MDT:NYSE) since the previous trading day is -3.5294%.
What is the most recent average sentiment score for MEDTRONIC PLC (MDT:NYSE)?
The most recent average sentiment score for MEDTRONIC PLC (MDT:NYSE) is 90 out of 100.
What is the most recent average sentiment for MEDTRONIC PLC (MDT:NYSE)?
The most recent sentiment for MEDTRONIC PLC (MDT:NYSE) is .
SEC-8K** Filing Available For MEDTRONIC PLC (MDT:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.